19 - 21 June, 2017 | Zurich, Switzerland

Media Center


Improving Patient Compliance via Packaging and Labelling

Patients rely on the information provided on a product to instruct them in a manner which will lead to safe and effective use. Therefore any flout in accuracy could have fatal consequences. In this top tips eBooK on improving patient compliance via packaging and labelling, we spoke with packaging specialist Karel van der Waarde about the the strategies used to enhance compliance with patients to help them follow the therapy plan more effectively.

International EU Compliance eHandbook Pharmaceutical Labelling

In response to the challenges faced in tracking and meeting the country specific labeling requirements of EU member states, Pharma IQ has produced this e-handbook based on a recent EU guideline.

Pharmaceutical Packaging and Labeling 2016 Trend Report

In this research report, Pharma IQ explores the trends, both those currently prominent and those which are emerging, within the pharmaceutical packaging and labeling market. Also, Suzanne Ivory, Head of Quality at Perigord provides insight into overcoming artwork obstacles on the route to market.

How To Manage Your Packaging And Labelling Partners

To ensure packaging and labelling streams are compliant and implemented both swiftly and cost effectively each stakeholder must perform their task in the correct sequence, using the right information and tools. With this in mind, Pharma IQ examines some of the latest tech and trends utilised in the process of managing packaging and labelling partners within pharma.

Packaging and Labelling Market Trend Report: 2017 Edition

This 2017 report provides a snapshot of the industry’s status as it stands today and gives valuable insights on: packaging and labelling regulatory compliance, artwork management, new technologies, patient compliance and tamper evidence packaging features. Commentary on the findings provided by global specialist secondary packaging provider Essentra. Download your free copy today.


Combatting Malicious Tampering in Pharma: The Weakspots

This infographic assesses the top anti-tamper weaknesses experienced within pharmaceutical packaging and labelling.

White Papers

Top 20 Artwork Auditor Tips, artwork, auditing, pharmaceutical packaging, labelling

The top 20 things to consider when auditing pharmaceutical labelling and artwork content creation capabilities. This booklet is designed to help professionals in pharmaceutical packaging labelling and artwork activities to develop improved auditing techniques.


Why does packaging artwork matter?

Packaging artwork is an often forgotten back room process in most pharmaceutical companies, but the changing business environment has brought issues from this capability to the fore. Pharmaceutical and other healthcare companies are facing one of the most difficult periods in their history.

Exclusive Content

EU FMD Artwork Compliance Visual eguide

The global pharma market faces unprecedented complexities and pressures regarding the packaging and labelling of medicinal products. Ahead of the 2017 Packaging and Labelling Summit, this guide examines the changes required for pharmaceutical packaging to meet the requirements of EU Falsified Medicines Directive (FMD) and the crucial questions to ask in order to achieve compliance.


How to Deliver Cost Effective Pharmaceutical Global Artwork

Labelling and Artwork are still the highest causes of the recall of pharmaceutical products. Andrew Love, Vice President at Pharmaceutical Advisory Services, Be4ward Ltd, and former Director of Global Pack Management from GlaxoSmithKline, talks to Pharma IQ about his hopes to resolve these issues in the bid of patient safety.

White Papers

INDUSTRY REPORT: Serialisation in Pharma

Pharmaceuticals consistently rank within the top ten categories for counterfeit goods and the risk to products can vary from country to country. In response pharmaceutical manufacturers are investing more in product security initiatives, such as serialisation which involves coding products uniquely at the item level.

In this industry report we provide expert insight and analysis from key opinion leaders in the field on the trends in battling counterfeit drugs through serialisation.

Exclusive Content

Boehringer Ingelheim's Johannes Schoen on How to Prepare for the Falsified Medicines Directive

In this recent interview, Johannes Schoen, Supply Network Quality Management Anti-Counterfeitng, Boehringer Ingelheim speaks to Andrea Charles from Pharma IQ, following facilitating the "Anti-Counterfeiting: Falsified Medicines Directive and beyond" roundtable at Cool Chain Logistics Europe 2013. 

Sponsorship Information

Managing Your Packaging& Labeling Partners

In order to achieve innovative and cost effective packaging streams, it is vital that collaboration, both internally and externally, are managed effectively. To help you manage your partnerships and maximise ROI, Pharma IQ have put together a report that examines some of the latest technology and trends utilised in the process of managing packaging and labelling partners within pharma.


Top 3 Tips for Developing a Globally Applicable Labelling Strategy

Peter Schroeer, Director Europe, Quality Systems and Regulatory Affairs at Johnson & Johnson, joined Pharma IQ to talk about strategies for overcoming current compliance challenges the medical device market faces.


Don’t Get Lost in Translation – Reflections on Pharmaceutical Labelling

Mark Gibson, Consumer Information Specialist at Gibson Research Consultancy, joins Helen Winsor form Pharma IQ, to discuss packaging and labelling in the healthcare industry. In this exclusive interview, Gibson outlines the main considerations in labelling translation, the key challenges associated with translation validation, and how these can be overcome.

White Papers

Pharmaceutical Packaging & Labelling Strategy Insights

As pharmaceuticals come under greater regulatory scrutiny, companies have to evaluate their packaging and labelling processes to ensure compliance and reduce risk. We spoke with key opinion leaders from the industry to reveal the biggest obstacles they face in achieving excellence and reveal their top tips for an effective packaging and labelling strategy and process.

Top 20 Packaging Complexity Management Tips

Discover Top 20 things to consider to drive the maximum value out of your pharmaceutical packaging portfolio. This booklet takes the popular Top 20 Tips format to describe key features of a complexity management capability in an easy to digest format.


Falsification and Pharmacovigilance: What Do Patients Get to See and What Should They Do with It?

The ‘Falsified medicines directive’ (2011/62/EU) and the ‘Pharmacovigilance regulation’ (No 1235/2010) will influence some of the information that patients receive about medicines. In both the directive and the regulation, several forms of visual communication are mentioned.

In this discussion piece Dr Karel van der Waarde explores the impact of the latest falsification and pharmacovigilance regulation on pharmaceutical packaging.


Engagement, Automation & Simplification: 3 Steps to Optimising your Packaging Line

In this Pharma IQ interview Gianluca Fioravanti, Head of Packaging and Warehouse Operations, GlaxoSmithKline, shares his top tips for achieving overall equipment performance, optimising packaging lines and overcoming complexity within the packaging process.


Tamper Evidence in Pharma Packaging - Expert Insight eBook

The anti-counterfeit packaging market is forecasted to reach US$206.57 billion by 2021, just shy of doubling its 2016 figure of $107.26 bn. This growth is supported by the expanding pharma and food and beverage industries, with Asia Pacific set to take the largest market share. China is earmarked to lead the way in 2021 with its drive in manufacturing activities fueling that lead.

The anti-tampering market is littered with challenges to address: meeting EU FMD requirements, satisfying country specific requirements, preserving patient usability and not to mention outwitting resourceful counterfeiters. In this ebook we look at the road to meeting the 2019 FMD deadline, finding the most suitable anti tamper evidence feature as well as patient compliance and future trends in the industry.

Insight from:

Dieter Mößner
Edelmann GmbH/ Convenor of ISO TC 122 WG 15 “Tamper Verification Features on medicinal product packaging

Horst Kastrup
Senior RegulatoryAdvisor
MEDA Pharma